Ligustrazine reverts anthracycline chemotherapy resistance of human breast cancer by inhibiting JAK2/STAT3 signaling and decreasing fibrinogen gamma chain (FGG) expression

Liu, YL; Yan, ZX; Xia, Y; Xie, XY; Zhou, K; Xu, LL; Shi, YL; Wang, Q; Bi, JW

AMERICAN JOURNAL OF CANCER RESEARCH, 2020; 10 (3): 939